Kapoor R - Search Results

1

Energy failure in multiple sclerosis and its investigation using MR techniques.

Paling D, Golay X, Wheeler-Kingshott C, Kapoor R, Miller D. Paling D, et al. Among authors: kapoor r. J Neurol. 2011 Dec;258(12):2113-27. doi: 10.1007/s00415-011-6117-7. Epub 2011 Jun 10. J Neurol. 2011. PMID: 21660561 Review.

2

Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.

Paling D, Solanky BS, Riemer F, Tozer DJ, Wheeler-Kingshott CA, Kapoor R, Golay X, Miller DH. Paling D, et al. Among authors: kapoor r. Brain. 2013 Jul;136(Pt 7):2305-17. doi: 10.1093/brain/awt149. Brain. 2013. PMID: 23801742

3

Cerebral arterial bolus arrival time is prolonged in multiple sclerosis and associated with disability.

Paling D, Thade Petersen E, Tozer DJ, Altmann DR, Wheeler-Kingshott CA, Kapoor R, Miller DH, Golay X. Paling D, et al. Among authors: kapoor r. J Cereb Blood Flow Metab. 2014 Jan;34(1):34-42. doi: 10.1038/jcbfm.2013.161. Epub 2013 Sep 18. J Cereb Blood Flow Metab. 2014. PMID: 24045400 Free PMC article.

4

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial.

Kapoor R, Furby J, Hayton T, Smith KJ, Altmann DR, Brenner R, Chataway J, Hughes RA, Miller DH. Kapoor R, et al. Lancet Neurol. 2010 Jul;9(7):681-8. doi: 10.1016/S1474-4422(10)70131-9. Epub 2010 Jun 8. Lancet Neurol. 2010. PMID: 20621711 Clinical Trial.

5

Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial.

Raftopoulos R, Hickman SJ, Toosy A, Sharrack B, Mallik S, Paling D, Altmann DR, Yiannakas MC, Malladi P, Sheridan R, Sarrigiannis PG, Hoggard N, Koltzenburg M, Gandini Wheeler-Kingshott CA, Schmierer K, Giovannoni G, Miller DH, Kapoor R. Raftopoulos R, et al. Among authors: kapoor r. Lancet Neurol. 2016 Mar;15(3):259-69. doi: 10.1016/S1474-4422(16)00004-1. Epub 2016 Jan 26. Lancet Neurol. 2016. PMID: 26822749 Clinical Trial.

6

Phenytoin for neuroprotection - Authors' reply.

Kapoor R, Raftopoulos R, Altmann DR, Miller DH, Hickman SJ. Kapoor R, et al. Lancet Neurol. 2016 Aug;15(9):902-903. doi: 10.1016/S1474-4422(16)30094-1. Lancet Neurol. 2016. PMID: 27478948 No abstract available.

7

Upper cervical cord area in early relapsing-remitting multiple sclerosis: cross-sectional study of factors influencing cord size.

Rashid W, Davies GR, Chard DT, Griffin CM, Altmann DR, Gordon R, Kapoor R, Thompson AJ, Miller DH. Rashid W, et al. Among authors: kapoor r. J Magn Reson Imaging. 2006 Apr;23(4):473-6. doi: 10.1002/jmri.20545. J Magn Reson Imaging. 2006. PMID: 16521094

8

Axonal protection achieved in a model of multiple sclerosis using lamotrigine.

Bechtold DA, Miller SJ, Dawson AC, Sun Y, Kapoor R, Berry D, Smith KJ. Bechtold DA, et al. Among authors: kapoor r. J Neurol. 2006 Dec;253(12):1542-51. doi: 10.1007/s00415-006-0204-1. J Neurol. 2006. PMID: 17219031

9

Neuroprotection in multiple sclerosis: therapeutic strategies and clinical trial design.

Kapoor R. Kapoor R. Curr Opin Neurol. 2006 Jun;19(3):255-9. doi: 10.1097/01.wco.0000227034.85576.16. Curr Opin Neurol. 2006. PMID: 16702831 Review.

10

Serum neurofilament light as a biomarker in progressive multiple sclerosis.

Kapoor R, Smith KE, Allegretta M, Arnold DL, Carroll W, Comabella M, Furlan R, Harp C, Kuhle J, Leppert D, Plavina T, Sellebjerg F, Sincock C, Teunissen CE, Topalli I, von Raison F, Walker E, Fox RJ. Kapoor R, et al. Neurology. 2020 Sep 8;95(10):436-444. doi: 10.1212/WNL.0000000000010346. Epub 2020 Jul 16. Neurology. 2020. PMID: 32675076 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,691 results

Search Page

Filters